CHI3L2
Chitinase-3-like protein 2
Also known as: CH3L2_HUMAN, YKL-39, YKL39
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15782
- Gene
- CHI3L2
- Ensembl
- ENSG00000064886
- Chromosome
- 1
- Canonical length
- 390 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is similar to bacterial chitinases but lacks chitinase activity. The encoded protein is secreted and is involved in cartilage biogenesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Canonical amino-acid sequenceUniProt
390 residues, UniProt reviewed canonical sequence.
>Q15782|CHI3L2
1 MGATTMDQKS LWAGVVVLLL LQGGSAYKLV CYFTNWSQDR QEPGKFTPEN IDPFLCSHLI
61 YSFASIENNK VIIKDKSEVM LYQTINSLKT KNPKLKILLS IGGYLFGSKG FHPMVDSSTS
121 RLEFINSIIL FLRNHNFDGL DVSWIYPDQK ENTHFTVLIH ELAEAFQKDF TKSTKERLLL
181 TAGVSAGRQM IDNSYQVEKL AKDLDFINLL SFDFHGSWEK PLITGHNSPL SKGWQDRGPS
241 SYYNVEYAVG YWIHKGMPSE KVVMGIPTYG HSFTLASAET TVGAPASGPG AAGPITESSG
301 FLAYYEICQF LKGAKITRLQ DQQVPYAVKG NQWVGYDDVK SMETKVQFLK NLNLGGAMIW
361 SIDMDDFTGK SCNQGPYPLV QAVKRSLGSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHI3L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 187 nTPM
Expression across tissuesHPA
Tissue
- thymus: 187 nTPM
- salivary gland: 134 nTPM
- tonsil: 111 nTPM
- appendix: 106 nTPM
- lung: 70 nTPM
- spinal cord: 56 nTPM
Single-cell type
- lacrimal acinar cells: 597 nCPM
- salivary acinar cells: 571 nCPM
- alveolar cells type 2: 89 nCPM
- breast secretory cells: 85 nCPM
- salivary myoepithelial cells: 80 nCPM
- decidual stromal cells: 57 nCPM
Immune cell
- naive CD4 T-cell: 92 nTPM
- memory B-cell: 45 nTPM
- naive B-cell: 43 nTPM
- memory CD8 T-cell: 38 nTPM
- naive CD8 T-cell: 34 nTPM
- total PBMC: 27 nTPM
Brain region
- medulla oblongata: 117 nTPM
- thalamus: 61 nTPM
- pons: 59 nTPM
- white matter: 40 nTPM
- spinal cord: 26 nTPM
- cerebral cortex: 26 nTPM
ReferencesPubMed · IEDB
Publications for CHI3L2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis.
2001 · Ann Rheum Dis · RCR 1.1 · 46 citations - Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis.
2002 · J Rheumatol · RCR 1 · 45 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.43
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHI3L2 as an antibody target. Whether an autoantibody or antibody against CHI3L2 could matter depends on whether native CHI3L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHI3L2 is annotated as secreted, so native CHI3L2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CHI3L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...